29-Oct-2026 21:05:32
BPLPHARMAGeneral news
BHARAT PARENTERALS Q2 FY27 ; NET PROFIT AT ₹12 CR VS LOSS OF ₹9 CR (YOY), LOSS OF ₹4 CR (QOQ)
REVENUE UP 111% AT ₹136 CR (YOY), UP 45% (QOQ) EBITDA UP 2763% AT ₹24 CR (YOY), UP 176% (QOQ) MARGINS AT 17.3% VS 1.3% (YOY), 9.1% (QOQ)
BHARAT PARENTERALS LTD.